We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,956 results
  1. Gamma-glutamyl transpeptidase to platelet and gamma-glutamyl transpeptidase to lymphocyte ratio in a sample of Chinese Han population

    Background

    Gamma-glutamyl transpeptidase to platelet ratio (GPR) and gamma-glutamyl transpeptidase to lymphocyte ratio (GLR) are assumed to be...

    Weijie Chen, Danmian Hong, ... Li** Li in BMC Gastroenterology
    Article Open access 31 October 2022
  2. Gamma-glutamyl transpeptidase and indirect bilirubin may participate in systemic inflammation of patients with psoriatic arthritis

    Background

    Previous studies have suggested that systemic metabolic abnormalities are closely related to psoriatic arthritis (PsA). Gamma-glutamyl...

    Xu Wang, Yan Mao, ... Yaling Liu in Advances in Rheumatology
    Article Open access 30 October 2023
  3. Gamma-glutamyl transpeptidase has different efficacy on biliary atresia diagnosis in different hospital patient groups: an application of machine learning approach

    Objectives

    Gamma-glutamyl transpeptidase (GGT) is the most widely used biomarker in the early diagnosis of biliary atresia (BA), but its diagnostic...

    YuQi Sun, ShuYang Dai, ... Gong Chen in Pediatric Surgery International
    Article 17 June 2022
  4. Ultrasound characteristics combined with gamma-glutamyl transpeptidase for diagnosis of biliary atresia in infants less than 30 days

    Purpose

    To retrospectively assess the diagnostic performance of grey-scale ultrasound (US) characteristics and gamma-glutamyl transpeptidase (GGT)...

    Guotao Wang, Nan Zhang, ... Luyao Zhou in Pediatric Surgery International
    Article 19 May 2021
  5. Fasting hepatic insulin clearance reflects postprandial hepatic insulin clearance: a brief report

    Background

    Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes mellitus (T2DM). HIC was reported to decrease in...

    Tsuyoshi Okura, Risa Nakamura, ... Kazuhiro Yamamoto in Diabetology & Metabolic Syndrome
    Article Open access 20 December 2023
  6. Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience

    Background

    This study was designed to investigate clinical efficiency and application indications of hepatic lobe hyperplasia techniques for advanced...

    Qiang Guo, Maolin Wang, ... Yingmei Shao in BMC Surgery
    Article Open access 06 December 2022
  7. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio

    Background and purpose

    The present study aimed to establish a γ-glutamyl transpeptidase-to-albumin ratio (GAR)-based nomogram model to predict early...

    Shujie Pang, Yang Shi, ... Ning Yang in Journal of Gastrointestinal Surgery
    Article 04 May 2022
  8. Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis

    Background and aims

    Gamma–delta (γδ) T cells are involved in the development of diverse liver and autoimmune diseases, whereas the role of γδ T cells...

    Sha Chen, Tingting Lv, ... Jidong Jia in Hepatology International
    Article 14 January 2022
  9. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B

    Objective

    To evaluate the diagnostic accuracy of aspartate aminotransferase(AST)/ alanine transaminase (ALT), AST to platelet ratio index (APRI),...

    Juanxia Wang, **nce Sun, ... Yufeng Du in BMC Gastroenterology
    Article Open access 24 May 2024
  10. Hepatic Sarcoidosis: A Review of the Diagnosis and Management

    Purpose of Review

    Hepatic sarcoidosis is a type of granulomatous liver disease frequently presenting as an extrapulmonary manifestation of systemic...

    Allison Moser, Amanda Cheung in Current Hepatology Reports
    Article 20 January 2024
  11. Exploring the association between dietary fiber intake and hepatic steatosis: insights from NHANES

    Purpose

    The link between dietary fiber intake and Non-alcoholic fatty liver disease (NAFLD) is under exploration, yielding inconsistent findings....

    **ngxing Chen, Liying Fu, ... Yunchao Wang in BMC Gastroenterology
    Article Open access 10 May 2024
  12. Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis

    Background and aim

    The literature is sparse on the association between serum liver fibrosis markers and the development of hepatic decompensation in...

    Qingling Chen, Ling Mei, ... Jia Li in BMC Gastroenterology
    Article Open access 19 September 2023
  13. Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage

    A 53-year-old woman was diagnosed with liver dysfunction in August 20XX. Computed tomography (CT) revealed multiple hepatic AV shunts, and she was...

    Satoru Hagiwara, Toru Takase, ... Masatoshi Kudo in Clinical Journal of Gastroenterology
    Article Open access 04 March 2024
  14. Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction

    Purpose

    International expert panels proposed new nomenclatures, metabolic dysfunction-associated fatty liver disease (MAFLD) in 2020 and metabolic...

    Hee Jun Park, Sunyoung Lee, Jae Seung Lee in Abdominal Radiology
    Article 08 April 2024
  15. Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis

    Introduction

    Hepatic visceral crisis (VC), characterized by a rapid total bilirubin increase with disease progression, poses a life-threatening risk...

    Mirosława Püsküllüoğlu, Małgorzata Pieniążek, ... Marek Ziobro in Oncology and Therapy
    Article Open access 04 June 2024
  16. Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment

    Background

    Patients infected with Hepatitis C virus (HCV) are recommended to receive treatment with direct-acting antiviral agents (DAAs), which have...

    Bin Niu, Wenqian Zang, ... ** Li in BMC Gastroenterology
    Article Open access 03 April 2023
  17. Cholestatic Liver Disease in a Child with KIF12 Mutation

    Cholestatic liver diseases in children often have an underlying genetic defect. Genetic testing by next-generation sequencing has become a crucial...

    Arghya Samanta, Moinak Sen Sarma, ... Ujjal Poddar in Indian Journal of Pediatrics
    Article 03 November 2023
  18. Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin—a post-hoc analysis of the UTOPIA study

    Aims/Introduction

    The aim of the study was to evaluate the effects of tofogliflozin, a selective sodium-glucose cotransporter 2 inhibitor, on...

    Naoto Katakami, Tomoya Mita, ... Iichiro Shimomura in Diabetology International
    Article 10 February 2024
  19. Improvement of liver histology in hepatic sarcoidosis due to treatment with corticosteroids and ursodeoxycholic acid: a case report

    We report the case of a 48-year-old male with a history of pulmonary and ocular sarcoidosis. Non-caseating granulomas, identified histologically, are...

    Mayuko Kikuchi, Aritoshi Koizumi, ... Hitoshi Yoshiji in Clinical Journal of Gastroenterology
    Article 01 February 2024
  20. Development and validation of a model for early diagnosis of biliary atresia

    Background and aims

    Early diagnosis of biliary atresia (BA), particularly distinguishing it from other causes of neonatal cholestasis (NC), is...

    Zongrong Gong, Lin Lin, ... Chaomin Wan in BMC Pediatrics
    Article Open access 31 October 2023
Did you find what you were looking for? Share feedback.